$18.030
-0.719 (-3.99%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
JANX Prediction & Forecast by Similar Chart Analysis
Alphio's JANX stock price prediction model matches the current Janux Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.03 (-0.01%). The 1-week path is $18.16 (+0.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Janux Therapeutics Inc Stock?
Currently, Janux Therapeutics Inc is not a strong buy due to mixed signals from recent earnings and analyst ratings. The current price is $18.03, which is below the average analyst price target of $35, indicating potential upside. However, the company reported a disappointing Q2 EPS of -$0.35, missing expectations by $0.09, and has a negative net income of -$21,972,000 for Q2 2026, which raises concerns about profitability. The RSI is at 55.348, suggesting the stock is neither overbought nor oversold, and the recent 5-day change is +3.68%, showing some positive momentum. However, hedge funds are selling, with a 575.67% increase in selling activity over the last quarter, indicating a lack of confidence among institutional investors. Therefore, while there is potential for growth, the risks associated with current financial performance and market sentiment suggest holding rather than buying at this time.
JANX stock price ended at $18.03 on Friday, after losing -3.99%
Janux Therapeutics Inc (JANX) last closed at $18.03, losing -3.99%. These facts feed the 1-day and 1-week JANX price prediction above.
Forecast Drivers
Janux Therapeutics Inc (JANX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches JANX, ranked by similarity.
Seasonality analysis for JANX
Historically the probability of a positive August return for JANX is 66.67%. April offers the highest probability of a positive month at 67.19%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for JANX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $60.08 | $68.06 | $76.63 | +277.49% |
| Sep 2026 | $37.68 | $47.71 | $58.11 | +164.62% |
| Oct 2026 | $20.54 | $40.02 | $56.93 | +121.96% |
| Nov 2026 | $41.03 | $45.04 | $64.92 | +149.83% |
| Dec 2026 | $46.76 | $53.25 | $60.28 | +195.36% |
In 2026, Janux Therapeutics Inc (JANX) is projected to range from $20.54 to $76.63.
Janux Therapeutics Inc 2026 monthly forecast
In Aug 2026, Janux Therapeutics Inc is projected to average $68.06, with a low of $60.08 and high of $76.63.
In Sep 2026, Janux Therapeutics Inc is projected to average $47.71, with a low of $37.68 and high of $58.11.
In Oct 2026, Janux Therapeutics Inc is projected to average $40.02, with a low of $20.54 and high of $56.93.
In Nov 2026, Janux Therapeutics Inc is projected to average $45.04, with a low of $41.03 and high of $64.92.
In Dec 2026, Janux Therapeutics Inc is projected to average $53.25, with a low of $46.76 and high of $60.28.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.